Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,548.00p
   
  • Change Today:
      44.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 36,261
  • Market Cap: 1,675.82m
  • RiskGrade: 128
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 575.41 71.79 83.52p 30.0 n/a -17% 32.45p 1.3%
30-Jun-23 621.92 80.64 92.94p 26.9 2.4 +11% 36.03p 1.4%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
30-Jun-2022 575 575 n/a n/a n/a n/a
30-Jun-2023 622 621 n/a n/a n/a n/a
 
Earnings
30-Jun-2022 83.52p 83.52p n/a n/a n/a n/a
30-Jun-2023 92.94p 93.55p n/a n/a n/a n/a
 
Dividend
30-Jun-2022 32.45p 32.45p n/a n/a n/a n/a
30-Jun-2023 36.03p 35.23p n/a n/a n/a n/a
 
Recommendations
Strong Buy 4 4 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 1 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 5 5 0 0 0 0
 
Average Rec 9.00 9.00 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,548.00p
Change Today 44.00p
% Change 1.76 %
52 Week High 6,070.00
52 Week Low 2,234.00
Volume 36,261
Shares Issued 65.77m
Market Cap 1,675.82m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
81.82% below the market average81.82% below the market average81.82% below the market average81.82% below the market average81.82% below the market average
26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average
Income
84.39% below the market average84.39% below the market average84.39% below the market average84.39% below the market average84.39% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
49.64% above the market average49.64% above the market average49.64% above the market average49.64% above the market average49.64% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 27-Jun-2022

Time Volume / Share Price
15:55 273 @ 2,548.00p
15:55 11 @ 2,548.00p
15:55 14 @ 2,548.00p
15:55 38 @ 2,550.00p
15:55 37 @ 2,550.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page